爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

arrow generics limited - quetiapine - film coated tablet - 200 milligram

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

arrow generics limited - quetiapine - film coated tablet - 300 milligram

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml; timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 20mg/ml, 5mg/ml - active: dorzolamide hydrochloride 22.26 mg/ml equivalent to dorzolamide 20 mg/ml timolol maleate 6.83 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride hyetellose mannitol sodium citrate sodium hydroxide water for injection - arrow - dortim is indicated for the treatment of elevated intraocular pressure (iop) in patients with: · ocular hypertension · open-angle glaucoma · pseudoexfoliative glaucoma · or other secondary open-angle glaucoma's and who are: · insufficiently responsive to topical beta blocker monotherapy · currently receiving concomitant antiglaucoma therapies such as dorzolamide hcl and timolol maleate.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 100mg - modified release tablet - 100 mg - active: morphine sulfate pentahydrate 100mg excipient: hyetellose hypromellose magnesium stearate opadry grey oy-8238 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 10mg - modified release tablet - 10 mg - active: morphine sulfate pentahydrate 10mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry buff oy-3607 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 30mg - modified release tablet - 30 mg - active: morphine sulfate pentahydrate 30mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry violet 0y-6708 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 60mg - modified release tablet - 60 mg - active: morphine sulfate pentahydrate 60mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry orange oy-3533 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline);  ;  ;   - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline)       excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 purified water sodium starch glycolate titanium dioxide - arrow - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 55.95mg ((form-i) equivalent to 50mg sertraline);  ;  ;   - film coated tablet - 50 mg - active: sertraline hydrochloride 55.95mg ((form-i) equivalent to 50mg sertraline)       excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 purified water sodium starch glycolate titanium dioxide - arrow - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg;  ;  ;   - modified release tablet - 150 mg - active: venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150 mg       excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400   magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.